Skip to content

Hernia Surgery Urinary Retention

Post-operative Urinary Retention: A Prospective Randomized Study Identifying Patients at Risk and Reducing the Incidence Using Tamsulosin Pretreatment

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03027115
Enrollment
140
Registered
2017-01-20
Start date
2017-01-13
Completion date
2020-01-27
Last updated
2018-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hernia, Urinary Retention

Brief summary

Investigating whether pre-operative treatment with a selective alpha1-adrenoceptor antagonist affects the likelihood of male patients developing post-operative urinary retention following hernia repair.

Detailed description

The purpose of this study will be to investigate whether pre-operative treatment with a selective alpha1-adrenoceptor antagonist affects the likelihood of male patients developing post-operative urinary retention following hernia repair surgery. It is also of interest to determine whether or not a well-known urological screening tool, the IPSS, can identify patients at risk for urinary retention following elective laparoscopic or open hernia repair surgery. We will investigate if it is possible to pre-treat patients with a selective alpha1-adrenoceptor antagonist which we think can reduce the incidence of post-operative urinary retention and the associated adverse consequences, especially in those patients at higher risk.

Interventions

DRUGTamsulosin

Tamsulosin treatment for 7 days pre-operatively

Sponsors

Memorial Health University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Randomization to 1 of 2 possible arms, control and treatment

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male * 18 years of age * Presenting with hernia requiring surgical intervention

Exclusion criteria

* Intolerability of tamsulosin or related drugs * Investigator discretion * Unwillingness or inability to comply with protocol procedures and assessments

Design outcomes

Primary

MeasureTime frameDescription
Post-operative urinary retention2 weeksIncidence of post-operative urinary retention in patients undergoing hernia repair

Secondary

MeasureTime frameDescription
Effect of IPSS2 weeksthe variance in the relationship between treatment arm and incidence of post-operative urinary retention in patients undergoing hernia repair that is attributable to International Prostate Symptom Score (IPSS)

Countries

United States

Contacts

Primary ContactVishu Danthuluri, M.D.
vishwanathdanthuluri@memorialhealth.com256.665-6214
Backup ContactAndrew Schwemmer, M.D.
SchweAn2@memorialhealth.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026